Cover Image
市場調查報告書

子宮內膜異位症:流行病學的預測

Endometriosis - Epidemiology Forecast to 2027

出版商 DelveInsight Business Research LLP 商品編碼 524423
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
子宮內膜異位症:流行病學的預測 Endometriosis - Epidemiology Forecast to 2027
出版日期: 2018年03月01日 內容資訊: 英文 50 Pages
簡介

本報告提供全球主要7個國家的子宮內膜異位症的流行病學的預測相關分析,疾病概要和目前治療手法/演算法,在全球整體及各國 (美國、歐洲各國、日本) 的患者數的變化與預測 (今後11年份),今後的醫藥品開發、臨床實驗預測等的相關調查。

第1章 分析概要

第2章 疾病的背景情況和概要:子宮內膜異位症

  • 簡介
  • 分期
  • 種類
  • 病理生理學
  • 風險要素
  • 診斷方法
  • 治療方法
    • 腹腔鏡檢驗
    • 剖腹手術
    • 子宮切除術

第3章 主要7個國家 (7MM) 的子宮內膜異位症的流行病學

  • 分析的要點
  • 患者人口與預測參數
  • 美國
    • 子宮內膜異位症的患病人數 (今後12年份)
    • 子宮內膜異位症的已受診患者數 (今後12年份)
    • 子宮內膜異位症的可治療的患者數 (今後12年份)
  • (EU5歐洲主要5個國家)
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 日本

第4章 治療流程

  • 早期治療
  • 復發性子宮內膜異位症的治療方法
  • 反加 (Add-Back) 療法

第5章 現狀的未滿足需求

第6章 附錄

第7章 分析方法

  • 利用之資訊來源

第8章 DelveInsight的服務內容

第9章 免責聲明

第10章 關於DelveInsight

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DIEI0005

DelveInsight's 'Endometriosis - Epidemiology Forecast to 2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Endometriosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered:

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

Study Period: 2016-2027

Endometriosis Epidemiology:

The Endometriosis epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Endometriosis are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Endometriosis Epidemiology Segmentation:

The disease epidemiology covered in the report is segmented by total prevalence, diagnosed population and treatable cases of Endometriosis in 7MM.

The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, the prevalent cases of Endometriosis in 7 major markets was 13.8 Million in 2016 and, is expected to increase at a significant growth rate during the study period i.e., 2016-2027. Among 7MM United States account for highest incident population of Endometriosis i.e., 7.4 Million followed by United Kingdom.

Report Scope:

  • The report covers detailed overview of Endometriosis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of Endometriosis
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by total prevalence of Endometriosis, Diagnosed cases as well as treatable population of Endometriosis in 7MM

Key strengths:

  • 10 Year Forecast of Endometriosis epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Endometriosis
  • Diagnosed and Treatable population of Endometriosis in 7MM

Key assessments:

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Report Introduction

2. Disease Background and Overview: Endometriosis

  • 2.1. Introduction
  • 2.2. Stages
  • 2.3. Types
  • 2.4. Pathophysiology
  • 2.5. Risk Factors
  • 2.6. Diagnosis
  • 2.7. Treatment
    • 2.7.1. Laparoscopy
    • 2.7.2. Laparotomy
    • 2.7.3. Hysterectomy

3. Epidemiology of Endometriosis in 7MM

  • 3.1. Key Findings
  • 3.2. Population and Forecast Parameters
  • 3.3. United States
    • 3.3.1. Prevalent Cases of Endometriosis in the US (2016-2027)
    • 3.3.2. Diagnosed population of Endometriosis in the US (2016-2027)
    • 3.3.3. Treatable cases of Endometriosis in the US (2016-2027)
  • 3.4. EU5
    • 3.4.1. United Kingdom

3.4.1.1. Prevalent Cases of Endometriosis in the UK (2016-2027)

3.4.1.2. Diagnosed population of Endometriosis in the UK (2016-2027)

3.4.1.3. Treatable cases of Endometriosis in the UK (2016-2027)

    • 3.4.2. Germany

3.4.2.1. Prevalent Cases of Endometriosis in Germany (2016-2027)

3.4.2.2. Diagnosed population of Endometriosis in Germany (2016-2027)

3.4.2.3. Treatable cases of Endometriosis in Germany (2016-2027)

    • 3.4.3. France

3.4.3.1. Prevalent Cases of Endometriosis in Germany (2016-2027)

3.4.3.2. Diagnosed population of Endometriosis in Germany (2016-2027)

3.4.3.3. Treatable cases of Endometriosis in Germany (2016-2027)

    • 3.4.4. Italy

3.4.4.1. Prevalent Cases of Endometriosis in Germany (2016-2027)

3.4.4.2. Diagnosed population of Endometriosis in Germany (2016-2027)

3.4.4.3. Treatable cases of Endometriosis in Germany (2016-2027)

    • 3.4.5. Spain

3.4.5.1. Prevalent Cases of Endometriosis in Germany (2016-2027)

3.4.5.2. Diagnosed population of Endometriosis in Germany (2016-2027)

3.4.5.3. Treatable cases of Endometriosis in Germany (2016-2027)

  • 3.5. Japan
    • 3.5.1. Prevalent Cases of Endometriosis in Germany (2016-2027)
    • 3.5.2. Diagnosed population of Endometriosis in Germany (2016-2027)
    • 3.5.3. Treatable cases of Endometriosis in Germany (2016-2027)

4. Treatment Algorithm

  • 4.1. Initial Treatment
  • 4.2. Treatment of Recurrent Endometriosis
  • 4.3. Add-Back Therapy

5. Current Unmet Needs

6. Appendix

7. Report Methodology

  • 7.1. Sources Used

8. DelveInsight Capabilities

9. Disclaimer

10. About DelveInsight

List of Tables

  • Table 1 : Prevalent Cases of Endometriosis in United States (2016-2027)
  • Table 2 : Diagnosed Population of Endometriosis in United States (2016-2027)
  • Table 3 : Treatable Cases of Endometriosis in United States (2016-2027)
  • Table 4 : Prevalent Cases of Endometriosis in Germany (2016-2027)
  • Table 5 : Diagnosed Population of Endometriosis in Germany (2016-2027)
  • Table 6 : Treatable Cases of Endometriosis in Germany (2016-2027)
  • Table 7 : Prevalent Cases of Endometriosis in France (2016-2027)
  • Table 8 : Diagnosed Population of Endometriosis in France (2016-2027)
  • Table 9 : Treatable Cases of Endometriosis in France (2016-2027)
  • Table 10 : Prevalent Cases of Endometriosis in Italy (2016-2027)
  • Table 11 : Diagnosed Population of Endometriosis in Italy (2016-2027)
  • Table 12 : Treatable Cases of Endometriosis in Italy (2016-2027)
  • Table 13 : Prevalent Cases of Endometriosis in Spain (2016-2027)
  • Table 14 : Diagnosed Population of Endometriosis in Spain (2016-2027)
  • Table 15 : Treatable Cases of Endometriosis in Spain (2016-2027)
  • Table 16 : Prevalent Cases of Endometriosis in United Kingdom (2016-2027)
  • Table 17 : Diagnosed Population of Endometriosis in United Kingdom (2016-2027)
  • Table 18 : Treatable Cases of Endometriosis in United Kingdom (2016-2027)
  • Table 19 : Prevalent Cases of Endometriosis in Japan (2016-2027)
  • Table 20 : Diagnosed Population of Endometriosis in Japan (2016-2027)
  • Table 21 : Treatable Cases of Endometriosis in Japan (2016-2027)

List of Figures

  • Figure 1 : Prevalent Cases of Endometriosis in United States (2016-2027)
  • Figure 2 : Diagnosed Population of Endometriosis in United States (2016-2027)
  • Figure 3 : Treatable Cases of Endometriosis in United States (2016-2027)
  • Figure 4 : Prevalent Cases of Endometriosis in Germany (2016-2027)
  • Figure 5 : Diagnosed Population of Endometriosis in Germany (2016-2027)
  • Figure 6 : Treatable Cases of Endometriosis in Germany (2016-2027)
  • Figure 7 : Prevalent Cases of Endometriosis in France (2016-2027)
  • Figure 8 : Diagnosed Population of Endometriosis in France (2016-2027)
  • Figure 9 : Treatable Cases of Endometriosis in France (2016-2027)
  • Figure 10 : Prevalent Cases of Endometriosis in Italy (2016-2027)
  • Figure 11 : Diagnosed Population of Endometriosis in Italy (2016-2027)
  • Figure 12 : Treatable Cases of Endometriosis in Italy (2016-2027)
  • Figure 13 : Prevalent Cases of Endometriosis in Spain (2016-2027)
  • Figure 14 : Diagnosed Population of Endometriosis in Spain (2016-2027)
  • Figure 15 : Treatable Cases of Endometriosis in Spain (2016-2027)
  • Figure 16 : Prevalent Cases of Endometriosis in United Kingdom (2016-2027)
  • Figure 17 : Diagnosed Population of Endometriosis in United Kingdom (2016-2027)
  • Figure 18 : Treatable Cases of Endometriosis in United Kingdom (2016-2027)
  • Figure 19 : Prevalent Cases of Endometriosis in Japan (2016-2027)
  • Figure 20 : Diagnosed Population of Endometriosis in Japan (2016-2027)
  • Figure 21 : Treatable Cases of Endometriosis in Japan (2016-2027)
Back to Top